Stock ICAD ICAD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company iCAD, Inc.

Equities

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX
Other stock markets
 01:54:14 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.455 USD -1.69% Intraday chart for iCAD, Inc. -4.54% -16.94%
Apr. 11 ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium CI
Apr. 09 ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation CI

Business Summary

iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company’s Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. It also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution.

Number of employees: 68

Sales per Business

USD in Million2022Weight2023Weight Delta
Detection Products
57.3 %
- - 10 57.3 % -
Detection Services
42.7 %
- - 7 42.7 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
87.0 %
21 75.0 % 15 87.0 % -28.14%
France
6.4 %
1 2.7 % 1 6.4 % +47.11%
Other
3.0 %
1 3.7 % 1 3.0 % -50.35%
Belgium
1.3 %
0 0.5 % 0 1.3 % +68.09%
Europe
0.9 %
0 0.4 % 0 0.9 % +55.15%
Italy
0.6 %
0 0.7 % 0 0.6 % -43.58%
Switzerland
0.4 %
0 0.4 % 0 0.4 % -31.04%
Germany
0.4 %
0 0.5 % 0 0.4 % -54.03%

Managers

Managers TitleAgeSince
Dana Brown CEO
 Chief Executive Officer 59 22-01-09
Eric Lonnqvist DFI
 Director of Finance/CFO 49 21-01-31
Michelle Strong COO
 Chief Operating Officer - 23-04-30
Jonathan Go CTO
 Chief Tech/Sci/R&D Officer 59 06-09-30
Bill Keyes SAM
 Sales & Marketing - Dec. 31
Brian Testa HRO
 Human Resources Officer - 20-12-31
William Keyes
- -
Vasu Avadhanula PRN
 Corporate Officer/Principal - 23-04-30

Members of the board

Members of the board TitleAgeSince
Dana Brown CEO
 Chief Executive Officer 59 22-01-09
Andrew Sassine BRD
 Director/Board Member 59 15-12-08
Susan Wood BRD
 Director/Board Member 60 18-09-25
Michael J. Doyle BRD
 Director/Board Member 65 Jan. 22
Hedvig Hricak BRD
 Director/Board Member 77 Feb. 21
Rakesh Patel BRD
 Director/Board Member 50 18-09-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,725,861 24,995,463 ( 93.53 %) 185,831 ( 0.6953 %) 93.53 %

Shareholders

NameEquities%Valuation
Portolan Capital Management LLC
4.677 %
1,232,445 4.677 % 2 M $
Andrew Sassine
4.547 %
1,198,382 4.547 % 2 M $
Vanguard Global Advisers LLC
4.126 %
1,087,355 4.126 % 2 M $
First Eagle Investment Management LLC
2.579 %
679,525 2.579 % 1 M $
Renaissance Technologies LLC
1.982 %
522,190 1.982 % 840 726 $
Granahan Investment Management, LLC
1.618 %
426,409 1.618 % 686 518 $
PSM Vermögensverwaltung GmbH Langen v.d.Goltz, Dr. Prinz
1.308 %
344,786 1.308 % 555 105 $
BlackRock Institutional Trust Co. NA
1.306 %
344,201 1.306 % 554 164 $
Greenwood Capital Associates LLC
1.224 %
322,685 1.224 % 519 523 $
Geode Capital Management LLC
0.9084 %
239,376 0.9084 % 385 395 $

Company contact information

iCAD, Inc.

98 Spit Brook Road Suite 100

03062, Nashua

+

http://www.icadmed.com
address iCAD, Inc.(ICAD)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per Business

Sales per region

Ratings for iCAD, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.48 USD
Average target price
4.833 USD
Spread / Average Target
+226.58%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ICAD, INC. Stock iCAD, Inc.
-16.94% 39M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.16% 218B
DANAHER CORPORATION Stock Danaher Corporation
+7.17% 182B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.36% 132B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.88% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.10% 52.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 47.59B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.77% 39.96B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.45% 39.22B
RESMED, INC. Stock ResMed, Inc.
+26.72% 26.94B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ICAD Stock
  4. Company iCAD, Inc.